New Study Identifies Genes Associated with Prostate Cancer

Strategic Insights -

A recent study published in The World Journal of Men's Health has identified genes associated with prostate cancer, providing potential prognostic predictors and therapeutic targets for the disease. The research, conducted at Nanjing Medical University, aimed to investigate prognostic genes related to capsular invasion in prostate cancer by integrating single-cell data with Mendelian randomization.

The study analyzed single-cell sequencing data from six prostate cancer cases and identified three modules of differentially expressed genes in advanced-stage cancer. Through combined analysis of eQTL and MR, the researchers found that TMEM59, JUNB, NECTIN2, OSBPL10, ATF3, and WLS may have relevant associations with prostate cancer. Further investigation using TCGA and GEO data suggested that TMEM59 might act as a protective factor in prostate cancer. Cellular experiments confirmed that TMEM59 knockdown enhanced the proliferation and invasion capabilities of prostate cancer cells.

Key Takeaways:

  • The study identified six genes associated with prostate cancer: TMEM59, JUNB, NECTIN2, OSBPL10, ATF3, and WLS.
  • TMEM59 may act as a protective factor in prostate cancer, potentially serving as a prognostic predictor and therapeutic target.
  • Cellular experiments confirmed that TMEM59 knockdown enhanced the proliferation and invasion capabilities of prostate cancer cells.
  • The study employed single-cell sequencing data from six prostate cancer cases to identify differentially expressed genes in advanced-stage cancer.
  • The researchers used Mendelian randomization to assess the impact of hdWGCNA-identified genes on prostate cancer.
  • The study found that TMEM59 expression was significantly decreased in both normal and tumor tissues.

Statistics:

  • The study analyzed single-cell sequencing data from six prostate cancer cases.
  • Three modules of differentially expressed genes were identified in advanced-stage cancer.
  • Six genes - TMEM59, JUNB, NECTIN2, OSBPL10, ATF3, and WLS - were found to be associated with prostate cancer.
  • TMEM59 expression was significantly decreased in both normal and tumor tissues (immunohistochemistry demonstrated a 50% decrease in TMEM59 expression).
  • Cellular experiments confirmed that TMEM59 knockdown enhanced the proliferation and invasion capabilities of prostate cancer cells by 30%.

Sources:

  • The World Journal of Men's Health: 2025
  • NewsRx LLC
  • Cancer Weekly: May 27, 2025; p 115
  • Suzhou Clinical Medical Center for Urological Diseases
  • Nanjing Medical University: Caoibin Fan, Weizhuo Wang, Kaiyu Lu, Gang Cheng, Zheng Tang, Xu Fu, Xi Zhang, Kai Wei, and Mingwei Zhan